Even with the chilling effects of COVID-19, 2020 was the biggest deal year yet for private equity's investment in women's health practices (in terms of transaction count).
Members of the FOCUS Healthcare team counted approximately 25 closed dermatology transactions in 2020. Of those, fifteen were for small single-dermatologist practices. Ten deals were for two-dermatology practices, and five deals were for three-to six physician groups.
Gastroenterology deals have been accelerating, with eight closed transactions in Q4 2020 and another eight already closed (as of Jan 19) in 2021. We believe this will be a very big year for GI.
In many ways, the third wave of private equity investment in physician-owned businesses is starting to mature. We view this third wave as having started around 2015 with investments in ophthalmology and dermatology practices. Earlier investments in radiology and emergency medicine, or pure-play ASCs, are really part of an earlier wave.
The FOCUS healthcare team represents medical practices and ancillary businesses in specialties where private equity-backed consolidation is occurring. We track activity in key verticals and maintain strong relationships with private equity firms and their portfolio companies.
An investment banker specialized in medical practice deals can greatly improve the process and outcome of a sale. 
Members of the FOCUS Healthcare team counted approximately 25 closed dermatology transactions in 2020. Of those, fifteen were for small single-dermatologist practices. Ten deals were for two-dermatology practices, and five deals were for three-to six physician groups. 
We looked at completed ophthalmology deals in 2020 to understand different practice sizes that transacted. A couple of items are of note ... 
Gastroenterology deals have been accelerating, with eight closed transactions in Q4 2020 and another eight already closed (as of Jan 19) in 2021. We believe this will be a very big year for GI. 
In many ways, the third wave of private equity investment in physician-owned businesses is starting to mature. We view this third wave as having started around 2015 with investments in ophthalmology and dermatology practices. Earlier investments in radiology and emergency medicine, or pure-play ASCs, are really part of an earlier wave. 
